Phosphorus binders : trigger for intestinal diverticula formation in an ADPKD patient
Copyright by Società Italiana di Nefrologia SIN, Rome, Italy..
Hyperphosphoremia is common in patients with chronic kidney disease and is an important risk factor in this patient population. Phosphate binding drugs are a key therapeutic strategy to reduce phosphoremia levels, although they have significant side effects especially in the gastrointestinal tract, such as gastritis, diarrhoea and constipation. We report the case of a haemodialysis-dependent patient suffering from chronic kidney disease stage V KDIGO secondary to polycystic autosomal dominant disease; treated with phosphate binders, the case was complicated by the appearance of diverticulosis, evolved into acute diverticulitis.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
---|---|
Enthalten in: |
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia - 38(2021), 2 vom: 14. Apr. |
Sprache: |
Italienisch |
---|
Beteiligte Personen: |
Garozzo, Maurizio [VerfasserIn] |
---|
Themen: |
27YLU75U4W |
---|
Anmerkungen: |
Date Completed 25.10.2021 Date Revised 25.10.2021 published: Electronic Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM32407042X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM32407042X | ||
003 | DE-627 | ||
005 | 20231225185533.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||ita c | ||
028 | 5 | 2 | |a pubmed24n1080.xml |
035 | |a (DE-627)NLM32407042X | ||
035 | |a (NLM)33852218 | ||
035 | |a (PII)2021-vol2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a ita | ||
100 | 1 | |a Garozzo, Maurizio |e verfasserin |4 aut | |
245 | 1 | 0 | |a Phosphorus binders |b trigger for intestinal diverticula formation in an ADPKD patient |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.10.2021 | ||
500 | |a Date Revised 25.10.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright by Società Italiana di Nefrologia SIN, Rome, Italy. | ||
520 | |a Hyperphosphoremia is common in patients with chronic kidney disease and is an important risk factor in this patient population. Phosphate binding drugs are a key therapeutic strategy to reduce phosphoremia levels, although they have significant side effects especially in the gastrointestinal tract, such as gastritis, diarrhoea and constipation. We report the case of a haemodialysis-dependent patient suffering from chronic kidney disease stage V KDIGO secondary to polycystic autosomal dominant disease; treated with phosphate binders, the case was complicated by the appearance of diverticulosis, evolved into acute diverticulitis | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Letter | |
650 | 4 | |a acute diverticulitis | |
650 | 4 | |a chronic kidney disease | |
650 | 4 | |a diverticulosis | |
650 | 4 | |a hyperphosphoremia | |
650 | 4 | |a phosphate binding drugs | |
650 | 4 | |a polycystic autosomal dominant disease | |
650 | 7 | |a Phosphorus |2 NLM | |
650 | 7 | |a 27YLU75U4W |2 NLM | |
700 | 1 | |a Gullè, Concetta Luisa Monica |e verfasserin |4 aut | |
700 | 1 | |a Clementi, Anna |e verfasserin |4 aut | |
700 | 1 | |a Milone, Filippo |e verfasserin |4 aut | |
700 | 1 | |a Battaglia, Giovanni Giorgio |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia |d 1997 |g 38(2021), 2 vom: 14. Apr. |w (DE-627)NLM093699778 |x 1724-5990 |7 nnns |
773 | 1 | 8 | |g volume:38 |g year:2021 |g number:2 |g day:14 |g month:04 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 38 |j 2021 |e 2 |b 14 |c 04 |